GlassScriptPhysician profile
Alice H Meyer
NPI 1295074953
$2,328.61
in general payments reported to CMS, 2019-2025
11 companies · $658 in 2025
The $658 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.34 · 2022: $205 · 2023: $605 · 2024: $822 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $613.11 | 2023-2025 | Talvey, Tecvayli, Imbruvica |
| Astellas Pharma US INC | $367.65 | 2024-2025 | Xospata, Vyloy |
| Jazz Pharmaceuticals INC. | $258.29 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $232.43 | 2023 | Opdivo, Reblozyl |
| Eisai INC. | $204.92 | 2022 | |
| Astellas Pharma Global Development | $177.93 | 2023-2024 | Padcev |
| Madrigal Pharmaceuticals | $127.07 | 2025 | Rezdiffra |
| Incyte Corporation | $125.00 | 2025 | Niktimvo |
| Bayer Healthcare Pharmaceuticals INC. | $91.58 | 2023 | |
| Amgen INC. | $91.29 | 2024 | |
| Eusa Pharma (US) LLC | $39.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.